News

Investors on High Alert: Neogen Corporation Legal Update

Investors on High Alert: Neogen Corporation Legal Update

Investors Urged to Act on Neogen Corporation Class Action Lawsuits

Attention investors of Neogen Corporation (NASDAQ: NEOG), it is crucial to stay informed about potential legal actions surrounding the company. ClaimsFiler, a reputable shareholder information service, has been actively reaching out to investors who might have experienced significant losses, urging them to file lead plaintiff applications for a class-action lawsuit.

Understanding the Securities Class Action Lawsuit

This legal action stems from allegations against Neogen and its executives for failing to disclose vital information during a specified class period. Such failures have legal ramifications under federal securities laws and could impact shareholders adversely.

Key Dates for Investors

Investors should note the approaching deadline for filing lead plaintiff applications. Those who purchased shares between January 5, 2023, and June 3, 2025, are encouraged to act quickly. The deadline to file is September 16, 2025. The case is currently ongoing in the United States District Court for the Western District of Michigan, making it imperative for affected parties to stay engaged.

Impact of Recent Company Announcements

The financial outlook for Neogen Corporation has changed significantly recently. On April 9, 2025, the company reported a quarterly revenue decrease of 3.4%, totaling $221 million. This downturn was attributed to various integration issues and resulted in a revised fiscal guidance. Furthermore, the departure of the company's CEO did not help the stock, which saw a drastic 28% drop to approximately $5.02 per share on the news. The stock continued to fall, decreasing an additional 17% shortly after as projections for EBITDA margins reflected a troubling trend.

The Role of ClaimsFiler in This Situation

ClaimsFiler’s mission is to empower investors to claim their rightful share from securities class action settlements. By providing tools and resources that enable investors to understand their legal standing, ClaimsFiler aims to strengthen their chances of recovery. They offer a user-friendly platform that allows investors to register for free, access essential information, submit claims, and consult with legal experts at Kahn Swick & Foti, LLC.

What to Expect Moving Forward

As this lawsuit proceeds, shareholders of Neogen Corporation should remain vigilant and informed about developments. Engaging with legal counsel and utilizing resources like ClaimsFiler could significantly impact their ability to recover losses. By taking timely action, investors can ensure that their voices are heard during legal proceedings.

What is the Class Period for the Neogen lawsuit?

The Class Period for the lawsuit against Neogen Corporation spans from January 5, 2023, to June 3, 2025.

How can I file a lead plaintiff application?

Investors can file a lead plaintiff application through ClaimsFiler, which provides guidance on the process.

What were the major effects on Neogen's stock recently?

The stock suffered a notable decline, plunging 28% after the quarterly report and falling an additional 17% shortly after the CEO's departure.

Who is Kahn Swick & Foti, LLC?

Kahn Swick & Foti, LLC is a law firm that supports investors in understanding their legal options and provides evaluations for potential claims.

How can ClaimsFiler assist investors?

ClaimsFiler helps investors recover losses by providing access to essential information and support for submitting claims related to securities class action lawsuits.

Frequently Asked Questions

What is the main allegation against Neogen Corporation?

Neogen Corporation is accused of failing to disclose important financial information leading to investor losses during the class period.

Where can investors get more information about their case?

Investors are encouraged to visit ClaimsFiler's website for additional resources and assistance regarding their situation.

When will the next updates on the Neogen case be available?

Updates will be provided as the legal proceedings unfold, and shareholders should keep an eye on news channels and ClaimsFiler's communications.

Can I still join the lawsuit if I just learned about it?

Yes, as long as you fit the class period criteria, you can still participate and file your application before the deadline.

What steps should I take if I am an investor in Neogen?

If you are an investor, assess your losses, consult the ClaimsFiler for assistance, and consider filing a lead plaintiff application promptly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

I AM ALS Celebrates Major Reauthorization Victory

Updated Category News Views 84

Historical Milestone in ALS Advocacy With the stroke of a pen, the ACT for ALS rose like a phoenix, securing much-needed stability for those locked in a relentless battle against this ravaging disease. But hey, it wasn't without sweat and elbow grease from a fiercely dedicated group. As the President signed this game-changer into law, I AM ALS and its army of advocates...

Continue Reading
Black Friday Doubt Grows: Just 54% Trust Real Deals

Updated Category News Views 43

Do Shoppers Believe in Black Friday Anymore? You'd think by now, retailers would have cracked the code on building trust with their customers. But guess what? A fresh survey from Boston Consulting Group reveals only 54% of consumers buy the whole Black Friday discount story. That's barely more than flipping a coin. Promotion Fatigue: The Trust Buster Funny thing,...

Continue Reading
WeSalute's 'Heroes Meet Heroes' Unites Military, Athletes

Updated Category News Views 52

Every now and then, something stirs the soul in a way that neither Wall Street nor Main Street quite can. The 14th annual 'Heroes Meet Heroes' event by WeSalute is poised to do just that. Celebrating Service Through Shared Experiences WeSalute has been a cornerstone for veteran recognition for over two decades, fostering a sense of unity between military service members...

Continue Reading
Protalix to Reveal Q3 2026 Results Amid Rare Disease Push

Updated Category News Views 97

Looking Ahead to Protalix's Q3 Revelation Nobody's pretending it's a cakewalk to stay ahead in the biopharma sector, especially when you're tangoing with the unpredictable world of rare disease therapeutics. But here we are, with Protalix BioTherapeutics scheduling their third-quarter financial results announcement for November 10, 2026. If you've been tracking them—or...

Continue Reading
Seaboard's Q3 Financials: A Mixed Bag for Investors

Updated Category News Views 103

Eyeing Seaboard's Earnings: What's the Deal? Seaboard Corporation just dropped its earnings report for the third quarter, and boy, it's a doozy. The numbers show a mixed bag—like finding out your favorite team won, but your best player got benched with an injury. On the surface, we've got a rise in net sales, but dig a little deeper, and the cracks start to show. Sales...

Continue Reading
Magnum Ice Cream Embraces Centric Software for PLM Boost

Updated Category News Views 20

Centric Software Steps Into the Ice Cream Game Revolutionizing the digital landscape of The Magnum Ice Cream Company (TMICC), Centric Software has been called to the plate to drive transformation in this global ice cream behemoth. With operations in over 80 countries and a portfolio as diverse as your neighborhood freezer section, TMICC's collaboration with Centric is set...

Continue Reading
Ian Marx Wins Pro Bono Honor at NJ Legal Awards

Updated Category News Views 81

A Champion in Legal Advocacy How often do we hear about a lawyer choosing the unglamorous path of pro bono work over the high-stakes allure of corporate law? Slam-dunk, you don’t. At the New Jersey Legal Awards, Ian S. Marx from Greenberg Traurig broke the mold, snagging the 'Pro Bono Lawyer of the Year' award. This isn’t just some pat on the back; it's recognition of...

Continue Reading
3M's Huge Settlement: Navigating A Looming Legal Fog

Updated Category News Views 94

The latest chapter in 3M’s legal saga reads like a courtroom drama, but this time, the company's shelling out big bucks to sidestep prolonged courtroom battles. They're committing to a $5.8 billion payout over several years, aiming to put a lid on a massive batch of PFAS-related lawsuits. It’s like they’re cleaning the spill with a velvet mop, but the trick is...

Continue Reading
Pentixapharm Advances PANDA Study, Hosts Earnings Call

Updated Category News Views 24

Pentixapharm Poised for PANDA Progress Picture a couple of ducks on a pond, calm on top but paddling like hell beneath the surface. That's Pentixapharm right now, charging ahead with their Phase 3 PANDA study while gearing up to spill the beans in an upcoming webcast. It's a biotech chess game, and these folks might just be positioning to yell 'checkmate' down the line....

Continue Reading
Surgical Planning Associates Expands HipInsight Options

Updated Category News Views 129

A Broader Horizon for Hip Surgery Planning Well, here we go—a medical technology play that's actually stirring things up, and not just blowing smoke. Surgical Planning Associates (SPA)—a name you might wanna keep an eye on—is turning heads with their HipInsight System. Just this week, they let it be known they've added five more implant systems to their 3D...

Continue Reading

Top 5 Most Recently Viewed Articles

Snap Inc. Faces Securities Class Action Lawsuit Claims

Updated Category News Views 212

Snap Inc. Faces Legal Challenges Over Securities Claims Snap Inc. finds itself amidst a legal storm as investors raise concerns regarding potential securities law violations. Recently, Levi & Korsinsky, LLP has taken on the significant task of representing investors affected by these alleged infractions. Understanding the Class Action Lawsuit This class action lawsuit is...

Continue Reading
Nightfood Holdings Inc. Leads AI Revolution in Hospitality Business

Updated Category News Views 179

Nightfood Holdings Inc. at the Vanguard of AI Technology As industries grapple with ongoing labor shortages and escalating consumer demands, companies are increasingly embracing the power of artificial intelligence (AI) to propel their operations forward. Nightfood Holdings Inc. is not just a participant but a leader in this transformative journey within the hospitality...

Continue Reading
DVIGear Unleashes Innovative DisplayNet AVoIP Solutions

Updated Category News Views 168

DVIGear Showcases Cutting-Edge Technology at InfoComm DVIGear, a prominent manufacturer in the digital connectivity sector, is gearing up to make a major impact at InfoComm 2025. From June 11-13, attendees at Booth 2221 will have the opportunity to engage with the company’s advanced signal distribution products. Highlighting the event will be the DisplayNet AVoIP...

Continue Reading
Discover the Growth Potential of Advanced Drainage Systems

Updated Category News Views 188

Understanding the Investment in Advanced Drainage Systems Advanced Drainage Systems (NYSE: WMS) has shown remarkable performance over the past decade, outstripping the overall market with a notable annualized return of 16.75%. This impressive figure translates to a substantial 4.29% increase compared to other market benchmarks. Investment Insights from Ten Years Ago...

Continue Reading
Understanding the Rising Short Interest in Targa Resources

Updated Category News Views 160

Exploring Targa Resources's Short Interest Trends Targa Resources's short interest, represented by the stock ticker TRGP, has seen a significant increase recently, rising by 4.66%. Currently, the company reports having 3.79 million shares sold short, which equates to approximately 2.02% of all its available shares for trading. This uptick in short positions suggests that...

Continue Reading